Literature DB >> 19608681

Transient loss of consciousness in pediatric recipients of dimethylsulfoxide (DMSO)-cryopreserved peripheral blood stem cells independent of morphine co-medication.

Paul G Schlegel, Matthias Wölfl, Judith Schick, Beate Winkler, Matthias Eyrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19608681      PMCID： PMC2754973          DOI： 10.3324/haematol.2009.009860

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma.

Authors:  O Hequet; C Dumontet; A El Jaafari-Corbin; G Salles; D Espinouse; P Arnaud; C Thieblemont; F Bouafia; B Coiffier
Journal:  Bone Marrow Transplant       Date:  2002-03       Impact factor: 5.483

2.  Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation.

Authors:  P Windrum; T C M Morris
Journal:  Bone Marrow Transplant       Date:  2003-02       Impact factor: 5.483

3.  Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion.

Authors:  A M Júnior; C A Arrais; R Saboya; R D Velasques; P L Junqueira; F L Dulley
Journal:  Bone Marrow Transplant       Date:  2007-10-15       Impact factor: 5.483

4.  Respiratory depression and somnolence in children receiving dimethylsulfoxide and morphine during hematopoietic stem cells transplantation.

Authors:  Désirée Caselli; Veronica Tintori; Andrea Messeri; Stefano Frenos; Franco Bambi; Maurizio Aricò
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941

5.  Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells.

Authors:  R Hoyt; J Szer; A Grigg
Journal:  Bone Marrow Transplant       Date:  2000-06       Impact factor: 5.483

6.  Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres.

Authors:  P Windrum; T C M Morris; M B Drake; D Niederwieser; T Ruutu
Journal:  Bone Marrow Transplant       Date:  2005-10       Impact factor: 5.483

7.  Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study.

Authors:  G Cavaletti; N Oggioni; F Sala; G Pezzoni; E Cavalletti; P Marmiroli; M G Petruccioli; L Frattola; G Tredici
Journal:  Toxicol Lett       Date:  2000-12-20       Impact factor: 4.372

8.  Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion.

Authors:  Deborah Bauwens; Philippe Hantson; Pierre-François Laterre; Lucienne Michaux; Dominique Latinne; Marianne De Tourtchaninoff; Guy Cosnard; Danielle Hernalsteen
Journal:  Leuk Lymphoma       Date:  2005-11

9.  A randomized phase III clinical trial of autologous blood stem cell transplantation comparing cryopreservation using dimethylsulfoxide vs dimethylsulfoxide with hydroxyethylstarch.

Authors:  S D Rowley; Z Feng; L Chen; L Holmberg; S Heimfeld; B MacLeod; W I Bensinger
Journal:  Bone Marrow Transplant       Date:  2003-06       Impact factor: 5.483

10.  Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.

Authors:  Lutz P Mueller; Sebastian Theurich; Maximilian Christopeit; Wilfried Grothe; Anke Muetherig; Thomas Weber; Susanne Guenther; Gerhard Behre
Journal:  Eur J Haematol       Date:  2007-06       Impact factor: 2.997
View more
  7 in total

1.  Short-term cryopreservation of allogeneic stem cells for optimization of transplant conditions in children.

Authors:  Petra Sovinz; Wolfgang Schwinger; Herwig Lackner; Andrea Nebl; Sabine Sipurzynski; Christian Urban
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

Review 2.  Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.

Authors:  Z Shu; S Heimfeld; D Gao
Journal:  Bone Marrow Transplant       Date:  2013-09-30       Impact factor: 5.483

Review 3.  Principles and Protocols For Post-Cryopreservation Quality Evaluation of Stem Cells in Novel Biomedicine.

Authors:  Jingxian Xie; Marlene Davis Ekpo; Jian Xiao; Hongbin Zhao; Xiaoyong Bai; Yijie Liang; Guang Zhao; Dong Liu; Songwen Tan
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

Review 4.  Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas.

Authors:  Frank Peinemann; Lesley A Smith; Carmen Bartel
Journal:  Cochrane Database Syst Rev       Date:  2013-08-07

5.  Cryopreservation of dermal fibroblasts and keratinocytes in hydroxyethyl starch-based cryoprotectants.

Authors:  Yahaira Naaldijk; Adiv A Johnson; Annett Friedrich-Stöckigt; Alexandra Stolzing
Journal:  BMC Biotechnol       Date:  2016-12-01       Impact factor: 2.563

6.  Preservation media, durations and cell concentrations of short-term storage affect key features of human adipose-derived mesenchymal stem cells for therapeutic application.

Authors:  Fengli Zhang; Huaijuan Ren; Xiaohu Shao; Chao Zhuang; Yantian Chen; Nianmin Qi
Journal:  PeerJ       Date:  2017-05-17       Impact factor: 2.984

7.  Generation and characteristics of human Sertoli cell line immortalized by overexpression of human telomerase.

Authors:  Liping Wen; Qingqing Yuan; Min Sun; Minghui Niu; Hong Wang; Hongyong Fu; Fan Zhou; Chencheng Yao; Xiaobo Wang; Zheng Li; Zuping He
Journal:  Oncotarget       Date:  2017-03-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.